A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
Clinical trial NCT04095221 · COMPLETED
Trial details
- NCT number
- NCT04095221
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-17
- Primary completion
- 2025-02-18
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.